Show simple item record

dc.contributor.authorLin, Dan-Yu
dc.contributor.authorBaden, Lindsey R
dc.contributor.authorEl Sahly, Hana M
dc.contributor.authorEssink, Brandon
dc.contributor.authorNeuzil, Kathleen M
dc.contributor.authorCorey, Lawrence
dc.contributor.authorMiller, Jacqueline
dc.date.accessioned2022-06-10T11:53:23Z
dc.date.available2022-06-10T11:53:23Z
dc.date.issued2022-06-01
dc.identifier.urihttp://hdl.handle.net/10713/19105
dc.description.urihttps://doi.org/10.1001/jamanetworkopen.2022.15984en_US
dc.language.isoenen_US
dc.publisherAmerican Medical Associationen_US
dc.relation.ispartofJAMA Network Openen_US
dc.titleDurability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial.en_US
dc.typeArticleen_US
dc.identifier.doi10.1001/jamanetworkopen.2022.15984
dc.identifier.pmid35675078
dc.source.journaltitleJAMA network open
dc.source.volume5
dc.source.issue6
dc.source.beginpagee2215984
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record